Unveiling Ceremony of Industrial Transformation Base of near Infrared Fluorescence Imaging in Naviga

On October 17, the unveiling ceremony of the industrial transformation base of the "digital diagnosis and treatment equipment R & D" - near infrared fluorescence imaging intraoperative navigation system project of the Ministry of science and technology of the people's Republic of China was held in Jinwan, Zhuhai. It is reported that the achievement transformation of this project is expected to improve the accuracy of tumor intraoperative diagnosis and reduce the postoperative recurrence rate in the future through the real-time navigation and positioning of lesions during operation. The project is supported by national key projects. After entering Zhuhai International Health port, it will also help to improve the independent R & D level of regional medical device industry, inject energy into building the core competitiveness of Zhuhai Jinwan biomedical industry, and contribute to the localization of medical devices and the application and promotion of innovative products.

Nearly 1000 cases received good clinical feedback

In the past, structural imaging technology was widely used in the world for intraoperative navigation, while the "research and development of digital diagnosis and treatment equipment" used clearer and accurate molecular imaging technology, which was a pioneering move in the world and reflected the achievements of high-level independent scientific and technological research and development.

It is reported that the project of near infrared fluorescence imaging intraoperative navigation system undertaken by Beijing digital precision medical technology Co., Ltd. (hereinafter referred to as "Beijing digital precision medical") was listed as the project approved by the Ministry of science and technology in 2019 and won the support of key special projects.

Chi Chongwei, general manager of Beijing digital precision medicine, introduced that the project focuses on early diagnosis, precision diagnosis, minimally invasive treatment and precision treatment. According to the important clinical needs of accurate resection of liver cancer, through the research and development of near-infrared fluorescence imaging precision diagnosis and treatment technology and high-sensitivity imaging core components, Realize the high sensitivity and high-precision identification of nanomolar concentration developers in the cancer focus area, carry out in vivo fluorescence imaging, and form an intraoperative liver cancer precise surgical navigation system with completely independent intellectual property rights. This technology can realize the intraoperative real-time navigation and positioning of small cancer lesions (